News
Robert F. Kennedy Jr.’s actions at the CDC “put U.S. families at risk of dangerous and preventable illnesses,” they say.
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.
Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - ...
Fiona Havers, who oversaw CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
1d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...
The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on ...
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
today announced that data from the Company’s Phase 2a human challenge study of EDP-323 in healthy adults infected with respiratory syncytial virus (RSV) has been accepted for an oral ...
A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates ... funded in part by the US Department of Health and Human Services Biomedical Advanced Research and ...
Statistically Significant Reduction in Viral Load Confirmed in Clinical Trial Primary Endpoint Achieved In the highest dose group, there was an 88.94% reduction in viral load (P<0.0001) OSAKA, Japan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results